Krensavage Asset Management as of June 30, 2016
Portfolio Holdings for Krensavage Asset Management
Krensavage Asset Management holds 20 positions in its portfolio as reported in the June 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| United Therapeutics Corporation (UTHR) | 10.5 | $29M | 275k | 105.92 | |
| Orthofix International Nv Com Stk | 9.9 | $27M | 646k | 42.40 | |
| Impax Laboratories | 7.6 | $21M | 731k | 28.82 | |
| Enanta Pharmaceuticals (ENTA) | 7.2 | $20M | 907k | 22.05 | |
| Teva Pharmaceutical Industries (TEVA) | 7.2 | $20M | 397k | 50.23 | |
| Amgen | 6.9 | $19M | 126k | 152.15 | |
| Halyard Health | 6.7 | $19M | 575k | 32.52 | |
| Sucampo Pharmaceuticals | 6.5 | $18M | 1.6M | 10.97 | |
| Indivior | 5.7 | $16M | 4.7M | 3.34 | |
| CONMED Corporation (CNMD) | 5.7 | $16M | 329k | 47.73 | |
| Merck & Co (MRK) | 5.3 | $15M | 258k | 57.61 | |
| RTI Biologics | 4.7 | $13M | 3.6M | 3.59 | |
| Shire | 4.2 | $12M | 63k | 184.09 | |
| Invacare Corporation | 3.9 | $11M | 901k | 12.13 | |
| Allergan | 2.2 | $6.1M | 26k | 231.07 | |
| DepoMed | 1.5 | $4.3M | 218k | 19.62 | |
| Aviragen Therapeutics | 1.4 | $3.8M | 2.7M | 1.40 | |
| Derma Sciences | 1.3 | $3.6M | 911k | 3.94 | |
| Digirad Corporation | 0.9 | $2.5M | 481k | 5.15 | |
| Juniper Pharmaceuticals Incorporated | 0.7 | $2.0M | 288k | 7.01 |
